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From a subtractive cDNA library» we isolated several cDNA 
clones which showed differential expression between highly and 
lowly metastatic human melanoma cell lines. One clone, desig­
nated nmb, showed preferential expression in the low-meta- 
static cell lines and was chosen for further characterization. 
Sequence analysis revealed that this clone represents a novel 
gene, encoding a putative transmembrane glycoprotein which 
showed the highest homology to the precursor of pMELI7, a 
melanocyte-specific protein. nmf> RNA expression was absent in 
most tumor-cell lines tested and not restricted to the melano- 
cytic lineage. Transfection of a partial nmb cDNA into a highly 
metastatic melanoma cell line (BLM) resulted, in 2 of 3 transfec- 
tants, in slower subcutaneous tumor growth and, in I of 3 
transfectants, in reduction of the potential for spontaneous 
metastasis in nude mice.
© 1995 Wiley-Liss, Inc.
Melanocytic tumor progression is thought to evolve through 
several distinct stages, from normal melanocytes to highly 
invasive melanomas capable of metastasis (Clark et al., 1984; 
Hcrlyn et al, 1987). Monoclonal antibodies have been pre­
pared recognizing antigens with a preferential expression in 
one or a few stages of this process. Many of these molecules 
have been cloned and mainly represent adhesion molecules or 
growth-factor receptors (van Muijen et a lt 1990; Lehmann et 
a l, 1989; Johnson et a l, 1989). Another approach, using the 
differential and subtraction hybridization techniques, led to 
the isolation of calcyclin (Wcterman etal, 1992) and thymosin 
(3-10 (Wcterman et alf 1993/;) as potential progression markers 
for cutaneous melanoma. From a clinical point of view, such 
markers as indicators of metastatic potential would be very 
useful.
Although many markers have been isolated so far, it is useful 
to obtain a large panel of such markers, since a single marker 
or a few markers often show overlapping expression between 
benign and malignant stages. Many proteins that are uprcgu- 
lated during progression arc also important in the normal 
physiology of the cell. Thus, discrimination can only be 
achieved when a large panel of markers is used. The study of 
single markers can still be veiy useful, since it can provide us 
with a better insight in the pathogenesis of tumor progression.
cDNA clones, which are expressed only in non-metastic or 
low-metastatic cell lines or tumors, are candidates as tumor- 
suppressor genes. In the field of melanoma research, nm23 was 
isolated upon comparison of highly and lowly metastatic 
murine melanoma cell lines (Steeg et al, 1988). Although 
expression in ncvoccllular nevi was lower than in melanomas, 
/*w23 expression in melanomas, curiously, showed an inverse 
correlation with disease progression (Florencs et al, 1992).
p53, another potential tumor-suppressor gene, was origi­
nally reported to be mutated in a very large percentage of 
melanoma lesions (Stretch et alf 1991). However, later reports 
showed mutations in p53 only in a small percentage of 
melanoma cell lines (Akslcn and Morkve, 1992; Luca et a I, 
1993; Weiss et al, 1993). Another recently described gene, 
designated p i6, is frequently deleted or rearranged in mela­
noma cell lines (Kamb et al, 1994; Nobori et al., 1994). This 
gene encodes a cyclin-depcndent kinase-4 inhibitor which 
makes it a good candidate as a tumor-suppressor gene. The
exact extent and timing of these genes has yet to be deter­
mined.
In an attempt to describe a subtraction library, we isolated 
several differentially expressed cDNAs, 2 of which are ex­
pressed only in low-metastatic cell lines and corresponding 
xenografts and appear to represent novel genes. In this study, 
we describe the characterization of one of them.
MATERIAL AND METHODS 
Cell lines and xenografts
Human melanoma cell lines 1F6, 530, M14, McI57, BLM 
(van M uijen^ a/., 1991«), MV3 (van Muijen et a l, 1991 b), and 
MV1 (van Muijen et al, 1991c) were cultured as described 
before (Weterman et a1, 1993a). MV1 and MV3 were derived 
from the same melanoma lesion after 1 and 3 passages in nude 
mice, respectively (van Muijen et a 1, 1991c). The MV1 cells 
used for these experiments represent the lower metastatic 
phenotype, giving rise to spontaneous métastases in about 10% 
of the tumor-bearing animals. MV3 cells produce spontaneous 
métastasés in approximately 90% of the tumor-bearing ani­
mals. In this panel of cell lines, 1F6, 530, M.14 and McI57 are 
low-metastasizing cell lines, whereas BLM and MV3 represent 
the highly metastatic phenotype (van Muijen et al, 1991«). 
Approximately 3 x ID6 cells were used for s.c. inoculation into 
nude mice (nu/nu BALB/c; Bomholtgaard, Ry, Denmark).
A  Northern blot containing total RN A  of various cell lines 
was generously provided by Dr, P, Quax (Gaubius Institute 
IVVO, TNO, Leiden, The Netherlands). It contained RN A  
from: Bowes1 melanoma, HT1080 fibrosarcoma, Hela NIBSC 
and Hela S3 cervix carcinoma, MCF7 mammary carcinoma, 
A431 epidermoid carcinoma, Colo2Q5, CaCo2, HT29, SW620 
and SW480 colon carcinoma, KatoIII and I-IGT-1 gastric 
carcinoma, HepG2 hepatoma, K562, U937 DK  and I-IL60 
myeloid leukemia cell lines, and HS766T pancreas carcinoma 
cell lines. Human renal carcinoma cell lines, generously 
provided by Dr. J. Romijn (Rotterdam, The Netherlands), 
were all derived from the same patient (Weterman et al, 
1993b). Rat organs that were used for a Northern blot were: 
spleen, brain, liver, heart, muscle, kidney, testes, thymus, 
prostate, lung, bladder, intestines and stomach.
Human tissues
After excision, large sections of melanoma métastases were 
immediately frozen in liquid nitrogen and stored at -80°C. 
Melanoma métastasés were processed individually and were 
taken from patients other than those from whom nevi were 
removed. For RN A  isolations from common ncvoccllular nevi, 
dysplastic (atypical) or congenital nevi, a representative slice 
was taken. Most of the skin surrounding these lesions was 
removed before the material was frozen in liquid nitrogen. The 
remainder was processed for conventional histopathology. Dr. 
R. Koopman generously collaborated in obtaining fresh hu­
man material. It is guaranteed that this procedure did not
3To whom correspondence and reprint requests should be sent. Fax:
31 80540525.
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figure 1 -  Northern-blot analysis of human melanoma cell lines 
and xenografts. As a molecular-weight marker \  DNA restricted 
with Hindi!I was used; nmb was used as a probe. Lanes A, 1F6; B,
530; C3 M l4; D, Mel57; E, M VI; F, MV3 and G, BLM RNA 
isolated from cell lines; lanes H, 1F6; I, M l4; J, MV1; K, MV3 and. 
L, BLM RNA isolated from xenografts. As a control a ribosomal 
hybridization is shown.
hamper diagnosis. When nevi or normal skin tissue samples 
were used, 6 to 22 lesions from 6 to 17 patients were pooled in 
order to obtain enough material A  Northern blot containing 
smooth-muscle-denved tumors (3 leiomyomas and 7 leiomyo­
sarcomas) and normal uterus (4x)  and adjacent tissue (4x) 
was generously provided by Dr. T. Glouclemans (Utrecht, The 
Netherlands).
RNA isolation and Northern-blot analysis
Total RNA was isolated as described by Auifray and 
Rouge on (1980). 01'igo-deo.xy thymidine selections were per­
formed using oligo-deoxythymicline columns (type II, Collabo­
rative Research, Bedford, M A); 10 ju-g of total RNA were 
blotted on Hybond N + (Amersham, Aylesbury, UK) according 
to the procedure recommended by the manufacturer, after 
glyo.xylat.ion (McMaster and Carmichael, 1977) and size frac­
tionation on 1% agarose gels. To reconfirm equal loading, the 
blots were subsequently hybridized to ribosomal RNA probes.
Construction ofcDNA and subtraction libraries
cDNA libraries were constructed from 5 ¡ag of oligodeoxythy­
midine-selected RNA using a cDNA cloning kit (Invitrogen, 
San Diego, CA). For production of the subtracted library a 
sub tractor kit was used (Invitrogen). Construction was per­
formed as described before (Weterman at a I., 19936).
Hybridization
DNA probes were radiolabeled using the multi prime label­
ing method as recommended by Amersham. Hybridizations of 
cDNA libraries were performed as described ( Weterman et ciL, 
19936). Hybridizations of Northern blots were performed 
according to the method of Church and Gilbert (1984) with the 
addition of 0.1 mg denatured herring sperm DNA/m l of 
hybridization mixture. Hybridization of Southern blots was 
carried out as recommended by the manufacturer (Amer­
sham). Conditions of lower stringency were obtained by 
lowering the temperature for hybridization and washes down 
to 15°C below the optimal temperature.
FiGU.RE 2 -  Comp le te n ucl eotid.e s e q uenee of nmb (accession 
number X76534 EMBL human nmb RNA) and translated pre­
dicted protein. Brackets indicate the 5' end of the various PCR 
reactions,
( C ( AGAT ) GCCAGAAGAACACTGTTGCTCTTGGTGG.ACGGGCCCAGAGGAA
03 J. 12
TTCAGAGTTAAACCTTGAGTGCCTGCGTCCGTGAGAATTCAGC ATG GAA TGT CTC TAG TAT TTC
Glu Cya Leu Tyr Tyr Pha
139 166
CTG GGÀ TTT CTG CTC CTG GOT GCA AGA TTG CCA CTT GAT GCC GCC AAA CGA TTT
Leu Gl y Phe Leu Leu Leu Ala Ala Arg Leu Pro Leu Asp Ala Ala Lya Arg Phe
,193 220
CAT GAT GTG CTG GGC AAT GAA AGA CCT TCT GCT TAC ATG AGG GAG CAC A AT CAA
His Asp Val Leu Gly Ann Glu Arg Pro Ser Ala Tyr MET Arg Glu Mia Aon Gin
247 274
TTA AAT GGC TGG TCT TCT GAT GAA A AT GAC TGG A AT GAA AAA CTC TAC CCA GTG
Leu Aan Glv Trp Ser Ser Asp Glu .Ran Aap Trp Aan Glu Lys Leu Tyr Pro Val
301 32 7
TGG A AG CGG GGA G AC ATG AGG TGG AAA A AC TCC TGG AAG GGA GGC CGT GTG CAG
Trp Lys Arg Gly A0p MET Arg Trp Lya Aari Ser Trp Lyra Gly Gly Arg Val Gin
355 382
GCG GTC CTG ACC AGT GAC TCA CCA GCC CTC GTG GGC TCA AAT AT A ACA TTT GCG
Ala Val Leu Thr Ser Asp Ser Pro Ala Leu Val Gly Ser Atan H e  Thr Phe Ala
409 436
GTG AAC CTG ATA TTC CCT AGA TGC CAA AAG GAA GAT GCC AAT GGC AAC ATA GTC
Val Asn Leu lie Phe Pro Arg Cyg Gin Lye Glu Asp Ala Aon Gly Awn lie Val
463 490
TAT GAG AAG AAC TGC AGA AAT GAG GCT GOT TTA TCT GCT GAT CCA TAT CTT TAC
Tyr Glu Lys Aan Cys Arg Aari Glu Ala Gly Leu Ser* Ala Asp Pro Tyr Val Tyr
517 544
AAC TGG ACA GCA TGG TCA GAG GAC AGT GAG GGG GAA AAT GGC ACC GGC CAA AGC
Aan Trp Thr Ala Trp Ser Glu Asp ser Aap Gly Glu Awn Gly Thr Gly Gin Ser
571 S9B
CAT CAT AAC GTC TTC CCT GAT GGG AAA CCT TTT CCT CAC CAC CCC GGA TGG AGA
Hia His Aeri Val Phe Pro Asp Gly Lys Pro Phe Pro Hi a Hiss pro Gly Trp Axq
625 652
AGA TGG AAT TTC ftTC TAC GTC TTC CAO ACA CTT GOT CAG TAT TTC CAG AAA TTG
Arg Trp Asn phe lie Tyr Val Phe H:Uj Thr Leu Gly Gin Tyr Phe Gin Lya Leu
679 706
GGA CGA TGT TCA QTG AGA GTT TCT GTG AAC ACA GCC AAT GTG ACA CTT GGG CCT
Gly Arg Cya Ser Val Arg Val S e r Val Aan Thr AI a Aan Val Thr Lem Gly Pro
7 33 7 60
CAA CTC ATG GAA GTG ACT GTC TAC AGA AGA CAT GGA CGG GCA TAT GTT CCC ATC
Gin Leu MET Glu Val The Val Tyr Arg Arq HLei Gly Arg Ala Tyr Val Pro 11«
787 014
GCA CAA GTG AAA GAT GTG TAC GTG OTA ACA GAT CAG ATT CCT GTG TTT GTG ACT
A} a Gin Val Lya Asp Val Tyr Val Val Thr Aap Gin II® Pro Val Pha Val Thr
841 ' 667
ATG TTC CAG AAG AAC GAT CGA AAT TCA TCC GAC GAA ACC TTC CTC AAA OAT CTC
MET Phe Gin Lye Aan Asp Arg Aan Ser Ser Arp Glu Thr Pho Lou Lym A a p Leu
m'a 922
CCC ATT ATG TTT GAT GTC CTG ATT CAT GAT.’ CCT1 AGC CAC TTC CTC AAT TAT TCT
Pro Ile KBIT Phe ftap Val Leu II© His Awp Pro Ser Hi,« Phe Leu A « n Tyr 3«sr
949 976
ACC ATT AAC TAC AAG TGG AGC TTC GGG GAT AAT ACT GGC CTG TTT GTT TCC ACC
Thr lie Aan Tyr Lyei Trp Ser Phe Gly Aap Aan Thr Gly Lem ph<3 Vai Ser Thr
1003 1030
AAT CAT ACT GTG AAT CAC AGO TAT GTG CTC AAT GGA ACC TTC AGC CTT AAC CTC
Aan Hio Thr Vai Atan il i a Thr Tyr Val Leu Asm Gly Thr Phe Sesr Leu A a n Leu
1057 1084
ACT GTG AAA GCT GCA GCA CCA GGA CCT TGT CCG CCA CCG CCA CCA GCA CCC AGA
Thr Val. Lya Ala Ala Ala Pro Gly Pro Gya Pro Pro Pro Pro Pro Pro Pro Arg
' 1111 1137
CCT TCA AAA CCC ACC CCT TCT TTA GGA CCT GCT GGT GAC AAC CCC CTG GAG CTG
Pro Ser Lye Pro Thr Pro Ser Leu Gly Pro Ala Gly .Aap Aan Pro Lau Glu Leu
1.16 5 1192
AGT AGG ATT CCT GAT GAA AAC TGC CAG ATT AAC AGA TAT GGC CAC TTT CAA GCC
Ser Arg ile Pro A«p Glu Afein Cya Gin Ile Afin Arg Tyr Gly Hiei Phe Gin Aia
1219 ’ 1246
ACC ATC ACA ATT GTA GAG GGA ATC TTA GAG GTT AAC ATC ATC CAG ATG ACA GAC
Thr H e  Thr ile Val Glu Gly H e  Leu Glu Val An n Ile île Gin MET Thr A tip
127 3 1300
GTC CTG ATG CCG GTG CCA TGG CCT GAA AGC TCC CTA ATA GAC TTT GTC GTG ACC
Val Leu MET Pro Val Pro Trp Pro Glu Ser Sor Leu Ile A cip P ha Val Val Thr
1327 .1354
TGC CAA GGG AGC ATT CCC ACG GAG GTC TGT ACC ATC ATT TCT GAC CCC ACC TGC
Cya Gin Gly Ser Ila Pro Thr Glu Val Cya Thr 1.1© Ile Ser Aap Pro Thr Cyei
1301 .1407
GAG ATC ACC CAG AAC ACA GTC TGC AGC CCT GTG GAT GTG CAT GAG ATG TGT CTG 
Glu Ila Thr Gin Afin Thr Val Cysj Ser Pro Val A « p Val Aililp Glu MfiT Cya Lfâu
143 5 1462
CTG ACT GTG AGA CGA ACC TTC AAT GGG TCT GGG ACG TAC TGT GTC» AAC CTC ACC
Leu Thr Val Arg Arg Thr phe Aan Gly Ser Gly Thr Tyr Cya Val Aian Leu Thr
1409 1516
CTG GGG G AT GAC ACA AGC CTG GCT CTC ACG AGC ACC CT0 ATT TCT GTT CCT GAC
Leu Gly Aep A tip Thr Sor Leu Ala Lau Thr il ci t: Thr Leu Ilei S *; r Val Pro Aïip
1543 1570
AGA GAC CCA GCC TCG CCT TTA AGG ATG GCA AAC AGT GCC CTG ATC TCC GTT GGC
Arg Aap Pro Aia See pro Leu Arg HET Al?* Aan £ler Ala Leu H e  Ser Val Gly
1597 .1624
TGC TTG GCC ATA TTT GTC ACT GTG ATC TCC CTC TTG GTG TAC AAA AAA CAC AAG
Cya Leu Ala Ile Phe Val Thr Val Ile Sor Leu Leu Val Tyr L y a Lya fi i u Lya
1651 1678
GAA TAC AAC CCA ATA GAA AAT AGT CCT GGG AAT GTG GTC AGA AGC AAA GGC CTG
Glu Tyr Aan Pro Ile Glu Aon Ser Pro Gly Aan Vai Vai Arg Ser Lys? Gly Leu
1705 ' 1732
AGT GTC TTT CTC AAC CCT GCA AAA GCC GTG TTC TTC CCG GGA AAC CAG GAA AAG
Ser Val Phe Leu Aen Arg Ala Lya Aia Val Phe Phe Pro Gly Asm Gin Glu Lya
1759 1790
GAT CCG CTA CTC AAA AAC CAA GAA TTT AAA GGA GTT TCT T AA.ATTT C G A C C TT Ci TTT C
Aap Pro Leu Leu Lys Aan Gin Giù Phe Lyu Gly Val Bear .
1825 1861 




GAG AGGGAT T AT ACTGC AGGC AG CTT C AG CC AT GTTG TG AAACTG A Ï AAA AG CA ACTT AG C AAGG CTT CTT
2030 2074
t t c a t t a t t t t t t a t g t t t c a c t t a t a a a g t c t t a g g t a a c t a g t a g g a t a o a a a c a c t g t g t c c c g a g a g
2109 2145
T AAGG AG AG AAG CTACT ATTG ATT AG AG CCT A.ACCC AGGTT A ACTGC AAG AAG ACGCCGGAT ACTTTC AGC
2180 2216 
t t t c c a t g t a a c t g t a t g c a t a a a g c c a a t g t a g t c c a g t t t c t a a g a t c a t g t t c c a a g c t a a c t g a a t c
2251 2287
CC ACTTC AAT AC A C ACTC ATG AA CT C CTG A TG G AA C AA TAACAG GCCC AAG C CTG TGG T ATG ATG TG C A CA
2 322 2 350
c t t g c t a g a c t c a g a a a a a a t a c t a c t c t c a t a a a t g g g t g g g a g t a t t t t g g t o a c a a c c t a c t t t g c t t
2393 2429
g g c t g a g t g a a g g a a t g a t a t t c a t a t a t t c a t t t a t t c c a t g g a c a t t t a g t t a g t g c t t t t t a t a t a c c
2464 2 500
a g g c a t g a t g c t g a g t g a c a c t c t t g t g t a t a t t t c c a a a t t t t t g t a t a g t c g c t g c a c a t a t t t g a a a t
2535 2571
CATATATTAÀGACTTTCCAAAG ATG AGGTCCCTGGTTTTTCATGGCAACTTG ATC AGT AAGG ATTTCACCT
2606 2642
c t g t t t g t a a c t a a a a c c a t c t a c t a t a t g t t a g a c a t g a c a t t c t t t t t c t c t c c t t c c t g a a a a a t a a a
GTGTGGGAAGAGAC{A)n
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DNA sequencing and computer analysis
A set of deletion clones was constructed from cDNA inserts 
longer than 400-500 bp using the erase-a-base system (Pro- 
mega, Madison, WI). DNA fragments were ligated into 
M13mpl8, M13mpl9, pTZ or pGEM vectors and sequenced 
according to the dideoxy method as described by Sanger et a l 
(1980). Sequences were determined from both strands of the 
cloned cDNAs. The sequences of PCR products were deter­
mined using 3 independent PCR reactions. Searches for 
known sequences were performed using the Genbank and 
EMBL databases (Devereuxe/ al., 1984; Pearson and Lipman,
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Figuris 3 - Alignment of pMel l 7 (h) to the predicted protein of 
nmb (pnmb; a). Conserved cysteines are shown in boxes.
1988), Searches for motifs, alignments and structure predic­
tions were performed using the C A M M S A  programs M O ­
TIFS, P ILEUP, CLU ST A L V, BESTFIT, PEPTIDESTRUC- 
T U RE , PLO T ST RU C T U RE  and M E M B R A N E  P R O P E N ­
SITY, which are all part of the Wisconsin Package V  7.0 
(Devereuxef/a/., 1984).
Primer extension
A  149-bp Avall-Ndel restriction fragment (located at posi­
tion 331-480) was used as a primer. The extension reaction 
using reverse transcriptase was based on standard protocols 
(Sambrook et a l , 1989); 250 ng of double-stranded cDN A  was 
end-labeled using -y^P-ATP (Amersham) (specific activity 
3 x 107 cpm/jxg), then 4 x 105 cpm were added to 10 jxg of 
oiigo(-deoxythymidine)-selected MV1 R N A . After denatur- 
ation for 10 min at 85°C, annealing was performed at 45°C 
overnight. The extension reaction was performed at 37°C for 2 
hr using Moloney reverse trancriptase (BRL , Grand Island, 
NY), purified and analyzed on a sequencing gel containing 
sequence reactions as a size marker for the length of the 
extension products.
Cloning of the 5' end of nmb cDNA
The 5' end of nmb was cloned using the amplifinder kit 
(Clontech, Palo A lto, CA). Basically, after oligo-deoxy thymi­
dine-primed first-strand synthesis using 2 jxg of poly-A+- 
selected MV1 R N A  as a template, an anchor adaptor primer 
was ligated to this single-stranded cD N A  and amplified. For 
amplification, this primer and a specific primer (located at 
457-481) were used as P C R  primers (5 cycles, using 10 pmol of 
each primer and Taq polymerase). For further PCR  amplifica­
tion, another specific primer was used (located at position 
403-427), 35 Cycles of amplification were performed: denatur- 
ation for 45 sec at 94°C, annealing for 45 sec at 60°C, and 
extension for 90 sec at 72°C. Final extension was allowed to 
proceed for 7 min. P C R  products were analyzed on an agarose 
gel, treated with T4 D N A  polymerase to create blunt ends and 
cloned into a blunt-end vector.
Transfection
Transfection was performed in the BLM  cell line using 
lipofectin (BRL) and 20 jxg of pZ IPneo (Cepko et a l , 1984; 
Dotto et al, 1985) carrying the G418 resistance gene and a 
cD N A  clone (416-2656) or the resistance gene alone. Stable 
transfectants were selected in the presence of L mg/m I of G418 
in the culture medium. After selection, cells were grown in the 
presence of 0,25-0.5 mg/m  I G418.
In vivo assay for metastascs
Approximately 3 x 106 cells were inoculated sx. into nude 
mice. Tumor volumes were measured weekly and mice were 
maintained for 3 months unless the tumor size interfered with 
their health. After autopsy, the lungs were formalin-fixed, and
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BLM M o 1 
BLM 2 1 »
BLM 21.6 BLM Hpo 
BLM 91.6
BLM n to  1 
BLM 21B
BLM n«o 7 
BLM S1.1t
BLM n«0 10
F ig u r e  10 - Growth curves of the tumors from parental, neomycin- and nwb-transfected cell lines in nude mice. Values are given as a 
mean of all animals tested, (a) and (b) represent separately performed experiments. The values were based on 5 animals per cell line 
except for 21.19 (4 animals) in (a) and 10 (21.8, neol, neol6), 9 (21.19, BLM, neo7) or 7 animals in the case of 21.5 in (b).
'FABLE I - RATES OF SPONTANEOUS LUNG METASTASIS AFTER S.G  
INOCULATION OF NEOMYCÎN-, AW/i-TRANSFECTANTS, OR PARENTAL
CONTROLS IN NUDE MICE































The parental cell line was mock-transfected with lipofectin 
without adding DNA. A and B represent separately performed 
experiments.
*
parental control ccll lines were readily observed. In particular, 
clone 21.5 had a tendency to cluster at lower densities (Fig. 9). 
Growth rales in vitro were comparable. Growth rates in vivo 
and metastatic potential were examined in 2 separate sets of 
experiments. Upon inoculation in nude mice, tumor growth 
was delayed in the case of done 21.5, and to a lesser extent of 
clone 21.19 as compared to control cell lines (Fig. 10). After 
autopsy of the animals, the lungs were microscopically exam­
ined for métastases. In both sets of experiments, metastatic 
potential of 21.5 transfectants was reduced when compared to 
either parental or neomycin-resistent control transfcctant cell 
lines (Table I) while for the other 2 nm/>transfectants variable 
results were obtained.
DISCUSSION
Upon comparison of expression in highly and lowly meta­
static cell lines, several cDNAs were isolated showing a 
differential expression in the lowly and highly mctastatic 
human melanoma ccll lines and derived xenograft lesions. 
cDNA clones that showed a difference in expression of only 2- 
to 4-fold appeared to be related to growth and metabolism, e.g. 
ribosomal protein L8. Ribosomal cDNAs were also isolated 
from a tumor-enriched colon subtraction library, in which 
expression was detected in both well- and poorly-diifcrcnti- 
ated cells. Increased expression correlated with progression in 
2 pairs of cell lines derived from primary and metastatic lesions 
of the same patient (Kondoh et a l, 1992), Although the aim of 
this subtraction library was to enrich for sequences strongly 
expressed in the highly metastatic cell line, in 2 of the isolated 
cDNAs the pattern seen was the opposite of what was 
expected. Since an excess of MV1 sequences was used to
hybridize to MV3 sequences and the labeling of MV1 se­
quences by photobiotinylation, hybridization and separation of 
hybridized and non-hybridized cDNAs was not complete, part 
of this library consists of cDNAs strongly expressed in the 
low-metastatic MV1 cell line.
Sequence analysis of nmb, which showed expression only in 
the low-metastatic human melanoma ccll lines and xenografts, 
revealed that this clone represents a novel gene. Based on the 
presence of a signal sequence, a hydrophobic area of 27 
amino-acid residues, bordered by charged residues, which 
might cross the membrane in a single helical span, the 
prediction of integral membrane proteins by membrane propen­
sity programs for both signal sequence and transmembrane 
domain, and the homology with the precursor of p M e ll7  
melanocytic-specific protein (Kwon et a l, 1991) which also 
shows a transmcmbrane domain in this region, we assume that 
this done is encoding a transmembranc glycoprotein. Since 
M e l 17 was described as a member of a family to which gp75 
and tyrosinase also belong, which are both prominently ex­
pressed in melanocytic lesions, we also aligned our clone to 
these sequences and 5 regions of homology were detected (Fig. 
11). Overall identity and homology was 17.6% and 41.7% in 
the case of gp75, and 16.7% and 40.8% in the case of 
tyrosinase. All are characterized by a short non-coding region 
at the 5' end of the messenger, a signal peptide, and a 
transmcmbrane domain near the 3' end. Nearly all cysteines 
are conserved between tyrosinase and gp75 (Chintamaneni et 
a l, 1991), whereas all cysteines in the region preceding the 
transmcmbrane region are conserved between p M e ll7  and 
pnmb (Fig. 3). A lthough these 4 proteins clearly belong to one 
family, gp75 and tyrosinase are more similar to each other than 
to p M e ll7  or pnmb, and vice versa. Tyrosinase is the key 
enzyme in the synthesis of melanin pigment. Although tyrosi­
nase, gp75 and pM e ll7  are described as melanocyte-speciiic, 
and tyrosinase and gp75 are localized to the melanosomes, 
nmb is expressed in other tissues and tumor cell lines as well. 
Therefore, it cannot be present exclusively in the melano- 
somes.
Screening of several other ccll lines, rat organs and tumors 
indicated that the nmb gene has a restricted expression 
pattern, is not specific for the melanocytic lineage, and, 
secondly, is not well conserved during evolution of vertebrates.
Although nmb R N A  expression is not significantly higher in 
pooled specimens of nevocellular ncvi than in melanoma 
metastases, no final conclusions can be drawn about its 
potential as a protein marker for particular stages in melano­
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F ig u r e  11 - Multiple alignment of tyrosinase, gp75, pM el!7 and pnmb. Positions were based on mature peptides. The regions shown 
were part of the alignments of the complete sequences, as performed by the PILE UP or CLUSTALV alignment methods.
protein data. Earlier studies showed that, although an elevated 
R N A  expression of calcyclin was detected in melanoma 
metastases, this did not lead to a much higher expression of the 
protein since often only a small percentage of the tumor cells 
within such a lesion was stained (Weterman et a l, 1992, 
1993a).
Since the most important step in tumor progression is 
acquisition of the metastatic phenotype, we were interested to 
determine whether nmb could reduce the metastatic potential 
of a highly metastatic «mfr-negative melanoma cell line. Based 
on their expression pattern of nmb, calcyclin and thymosin 
(3-10, 3 /wiZ?~transfectants (21.5, 21.8 and 21.19) were chosen 
for further characterization. Calcyclin levels varied in the 
transfectants, which was not surprising since other experi­
ments using various melanoma cell lines showed that intrinsic 
calcyclin m R N A  levels varied widely after transfection experi­
ments or changes within the cell lines themselves (unpublished 
observations). In a preliminary series of experiments, a ten­
dency toward growth delay and reduction of metastatic poten­
tial was clearly present in the case of transfectant 21.5. The 
other transfectants tested, 21.8 and 21.19, showed varying rates 
of metastasis, possibly due to lower protein levels, independent 
of the R N A  level, which might condition the metastatic 
potential. It should be noted that a partial cDNA was 
transfected which lacked the signal peptide. Nevertheless, 
since the cytoplasmic part of the peptide was present in the 
transfectants, these observations are probably meaningful and 
will be extended in further studies.
ACKNOWLEDGEMENTS
The use of the services and facilities of the Dutch National 
Expertise Center CAOS/CAM M , under grants SON 326-052, 
and STW NCH99.1751 is gratefully acknowledged. We thank 
Mr. G. Stoopen, Mr. J. Berkeljon, Ms. I. Cornclisscn, Mr. K. 
Jansen and Ms. J. Lemmcrs for their technical assistance. This 
work was supported by the Dutch Cancer Society, grant 
NUKC 89-08.
REFERENCES
A kslen , L.A. and M orkve , O., Expression ofp53 protein in cutaneous 
melanoma. Int. J, Cancer; 52, 13-16 (1992).
A uffray , C. and Rougeon, F., Purification of mouse immunoglobulin 
heavy chain mRNAs from total myeloma tumor RNA, Europ. J, 
Biochem., 107, 303-314 (1980).
Cepko, C.L., R obe rts , B.E. and M u l l ig a n ,  R.C.} Construction and 
applications of a highly transmissible murine retrovirus shuttle vector. 
Cell, 37, 1053-1062 (1984).
C htn tam anen i, C.D., Ram say, M., C o lm an , M.-A, Fox, M.F., 
P ickard , R.T. and Kw on, B.S., Mapping the human CAS2 gene, the 
homologue of the mouse brown (b) locus, to human chromosome 
9p22-pter. Biochem. biophys. Res. Comm., 178, 227-235 (1991).
C hu rch , G.M. and G ilb e r t ,  W., Genomic sequencing. Proc. nat. 
Acad. Sci. (Wash.), 81,1991-1995 (1984).
C la rk , W.H., Jr ., E ld e r ,  D .E ., G u e r ry , D „  Epstein , M.N., Greene, 
M.H. and v a n  Horn, M„ A study of tumor progression: the precursor 
lesions of superficial spreading and nodular melanoma. Hum. Pathol, 
15,1147-1165 (1984).
D evereux , J., H a e b e r li, P. and Sm ithies, O ., A comprehensive set of 
sequence analysis programs for the VAX. Nucl Acids Res., 12.387-395 
(1984),
Dorro, J.P., P a rd a , L.S, and W e inbe rg , R.A., Specific genetic 
response of ras-transformed embryo fibroblasts to tumor promoters. 
Nature (LondJ, 318,472-475 (1985).
F lo renes , V.A., A am d a l, S., M y k le b o s t, O., M ae landsm o , G.M., 
B ru la n d , O.S. and F o d s tad , O., Levels of nw23 messenger RNA in 
metastatic malignant melanomas: inverse correlation to disease pro­
gression. Cancer Res., 52> 6088-6091 (1992).
H e r ly n , M., C la r k , W.H., R odeck , U., M a n c ia n ti, M.L., Jam- 
brosic, J. and Koprow ski, H., Biology of tumor progression in human 
melanocytes. Lab. Invest., 56,461-474 (1987).
Johnson , J.P., S tade , B.G., H o lzm a n n , B., Schw able , W. and
R ie th m u lle r , G., De novo expression of intercellular-adhesion mol­
ecule 1 in melanoma correlates with increased risk of metastasis. Proc. 
nat. Acad. Sci. (Wash.), 86,641-644 (1989).
Kamb, A., G ru is , N.A., W eaver-Fe ldhaus, J., Liu, Q., H arshm an , 
K., T av tig ian , S.V., S to cku rt, E., D ay, R.S., 111, Johnson, B.E. and 
Sko ln ick , M .H., A cell cycle regulator potentially involved in genesis 
of many tumor types. Science (Wash.), 264, 436-439 (1994).
K ondoh , N., Schweinfest, C.W ., H enderson , K.W . and Papas, T.S., 
Differential expression of S19 ribosomal protein, laminin-binding 
protein and human lymphocyte antigen class I messenger RNAs 
associated with colon carcinoma progression and differentiation. 
Cancer Res., 52, 791-796 (1992).
Kwon, B.S., Chintam aneni, C .D ., K ozak , C.A., C ope land , N.G., 
G ilb e r t ,  D .J., Jenkins, Nm B a r to n , D ., F rancku , U., Kobayashi, Y. 
and Kim, K.A., A melanocyte-specific gene, Pmell7, maps near the 
silver-coat-color locus on mouse chromosome 10 and is a syntenic 
region on human chromosome 12. Proc. nat. Acad. Sci. (Wash.), 88, 
9228-9232 (1991),
Lehmann, J .M , R ie th m u lle r , G . and Johnson , J.P., MUC18, a 
marker of tumor progression in human melanoma, shows sequence 
similarity to the neural ceil adhesion molecules of the immunoglobulin 
superfamily. Proc. nat. Acad. Sci. (Wash), 86, 9891-9895 (1989).
Luca, M., Lenzi, R m Leejackson, D m G u tm an , M., Fiduer, U . and 
B a re li, M., p53 Mutations are infrequent and do not correlate with 
the metastatic potential of human melanoma cells, int. ./. Oncol., 3, 
19-22 (1993).
M cM aste r , G.K. and C arm ichae l, G.G., Analysis of single and 
double-stranded nucleic acids on polyacrylamide and agarose gels 
using glyoxal and acridine orange. Proc. nat. Acad. Sci. (Wash.), 74,
4835-4838(1977).
N obori, T., M iu ra , K., W u, D.J., Lois, A., T akadayash i, K. and 
Carson , Dm Deletions of the cyclin-dependent kinasc-4 inhibitor gene 
in multiple human cancers. Nature (Land.J, 368, 753-756 (1994).
EXPRESSION OF A NOVEL GENE IN HUMAN MELANOMA 81
Pearson , W.R. and Lipman, D.J., Improved tools for biological 
sequence comparison. Proc. nat. Acad. Sei. (Wash.), 85, 2444-2448 
(1988).
Sam brook, J., F ritsch , E.F. and M an ia tis , T., Molecular cloning—a 
laboratory manual, pp. 7.79-7.83, Cold Spring Harbor Laboratory 
Press, Cold Spring Harbor, NY (1989).
Sanger, F., C ou lson , A .R ., B a r r e l l ,  B.G., Sm ith, A.J.H. and Roe , 
B.A., C loning in single-stranded bacteriophage as an aid to rapid 
sequencing./, mol, Biol, 143,161-178 (1980),
Steeg, P.S., B e v ila cq u a , G., Kopper, L., Thorgeisson, U.P., Tal- 
madge, J.E ., Lion a, L.A. and Sobel, M.E., Evidence for a novel gene 
associated with low tumor metastatic potential. J. nat. Cancer Inst., 80, 
200-205 (1988).
S t r e t c h ,  J.R., G a i t e r ,  K.C., R a l f k i a e r ,  E„ L a n e , D.P. and H a r r i s ,  
A.L., Expression of mutant p53 in melanoma. Cancer Res., 51, 
5976-5979 (1991).
van  M u ijen , G.N.P., C orne lissen , L.M., Jansen, C.F., F ig do r , C.G., 
Johnson , J.P., Bro ck e r , E.B. and R u ite r , D .J., Antigen expression 
of metastasizing and non-metastasizing human melanoma cells xeno- 
grafted into nude mice. Clin, exp, Metast, 9, 259-272 (199\a).
van M u ijen , G.N.P., Jansen, C.P.J., Corne lissen , L.M.A.H., Smeets, 
D.F.C.M., Beck, J.L.M, and R ijite r , D .J., Establishment and charac-
tcrization of a human melanoma cell line (MV3) which is highly 
metastatic in nude mice. Int. JCancer\ 48, 85-91 (19916).
van  M u ije n , G.N.P., R u ite r ,  D.J., H o e fa k k e r , S. and Jo hnson , J.P., 
Monoclonal antibody PAL-M1 recognizes the transferrin receptor and 
is a progression marker in melanocytic lesions. /. invest. Dermatol, 95, 
65-69 (1990).
van  M u ije n , G.N.P., W e te rm an , M.A J ., Q u ax , P.H.A., V erhe ije n , 
J.H. and R u ite r ,  D.J., Phenotypic profile of two human melanoma 
cell lines isolated from the same patient with different metastatic 
behavior in nude mice. Proc. Amer. Ass. Cancer Res., 32, 62 (1991c).
Weiss, J., Schw echhe im er, K m C avenee , W .K ., I- Ierlyn, M. and 
A rd e n , ICC., Mutation and expression of the p53 gene in malignant 
melanoma cell lines. Int. J. Cancer, 54, 693-699 (1993).
W e te rm an , M.A.J., S toopen , G.M., v a n  M u ije n , G.N.P., K uzn ick i, 
J., R u ite r , D.J. and B loem e rs , H.P.J,, Expression of calcyclin in 
human melanoma cell lines correlates with metastatic behavior in 
nude mice. Cancer Res., 52, 1291-1296 (1992).
W e te rm an , M.A.J,, v a n  M u ije n , G.N.P., B loem ers , H.P.J. and 
R u ite r ,  D.J., Expression of calcyclin in human melanocylic lesions. 
Cancer Res., 53, 6061-6066 (1993u).
W ete rm an , M.A.J., van  M u ije n , G.N.P., R u ite r ,  D.J. and B lo e m ­
ers, H.P.J., Thymosin £10 expression in melanoma cell lines and 
melanocytic lesions: a new progression marker for human cutaneous 
melanoma. Int, J. Cancer; 53,278-284 (1993/?).
